Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/ myelodysplastic syndrome and de novo acute myeloid leukemia.

Naoe T, Takeyama K, Yokozawa T, Kiyoi H, Seto M, Uike N, Ino T, Utsunomiya A, Maruta A, Jin-nai I, Kamada N, Kubota Y, Nakamura H, Shimazaki C, Horiike S, Kodera Y, Saito H, Ueda R, Wiemels J, Ohno R.

Clin Cancer Res. 2000 Oct;6(10):4091-5.

2.

The GST deletions and NQO1*2 polymorphism confers interindividual variability of response to treatment in patients with acute myeloid leukemia.

Barragan E, Collado M, Cervera J, Martin G, Bolufer P, Roman J, Sanz MA.

Leuk Res. 2007 Jul;31(7):947-53. Epub 2006 Nov 21.

PMID:
17118447
3.
4.

The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia.

Bolufer P, Collado M, Barragán E, Cervera J, Calasanz MJ, Colomer D, Roman-Gómez J, Sanz MA.

Haematologica. 2007 Mar;92(3):308-14.

5.

Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia.

Bolufer P, Collado M, Barragan E, Calasanz MJ, Colomer D, Tormo M, González M, Brunet S, Batlle M, Cervera J, Sanz MA.

Br J Haematol. 2007 Feb;136(4):590-6.

PMID:
17367411
6.

Association of CYP3A4 genotype with treatment-related leukemia.

Felix CA, Walker AH, Lange BJ, Williams TM, Winick NJ, Cheung NK, Lovett BD, Nowell PC, Blair IA, Rebbeck TR.

Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13176-81.

7.

Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1.

Haase D, Binder C, Bünger J, Fonatsch C, Streubel B, Schnittger S, Griesinger F, Westphal G, Schoch C, Knopp A, Berkovicz D, Krieger O, Wörmann B, Hilgers R, Hallier E, Schulz T.

Leuk Res. 2002 Mar;26(3):249-54.

PMID:
11792413
8.

MDR-1 and GST polymorphisms are involved in myelodysplasia progression.

Palodetto B, de Melo Campos P, Benites BD, de Lourdes Lopes Ferrari Chauffaille M, Velloso ED, Traina F, Saad ST.

Leuk Res. 2013 Aug;37(8):970-3. doi: 10.1016/j.leukres.2013.04.024. Epub 2013 May 17.

9.

Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia.

Allan JM, Wild CP, Rollinson S, Willett EV, Moorman AV, Dovey GJ, Roddam PL, Roman E, Cartwright RA, Morgan GJ.

Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11592-7. Epub 2001 Sep 11. Erratum in: Proc Natl Acad Sci U S A 2001 Dec 18;98(26):15394.

10.

Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients.

Rund D, Krichevsky S, Bar-Cohen S, Goldschmidt N, Kedmi M, Malik E, Gural A, Shafran-Tikva S, Ben-Neriah S, Ben-Yehuda D.

Leukemia. 2005 Nov;19(11):1919-28.

PMID:
16167058
11.

The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes.

Fabiani E, Fianchi L, Falconi G, Boncompagni R, Criscuolo M, Guidi F, La Brocca A, Hohaus S, Leone G, Voso MT.

Leuk Lymphoma. 2014 Jul;55(7):1538-43. doi: 10.3109/10428194.2013.845885. Epub 2013 Nov 1.

PMID:
24047476
12.

Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies.

Blanco JG, Edick MJ, Hancock ML, Winick NJ, Dervieux T, Amylon MD, Bash RO, Behm FG, Camitta BM, Pui CH, Raimondi SC, Relling MV.

Pharmacogenetics. 2002 Nov;12(8):605-11.

PMID:
12439220
13.

High frequency of NAD(P)H:quinone oxidoreductase 1 (NQO1) C(609)T germline polymorphism in MDS/AML with trisomy 8.

Zachaki S, Stavropoulou C, Koromila T, Manola KN, Kalomoiraki M, Daraki A, Koumbi D, Athanasiadou A, Kanavakis E, Kollia P, Sambani C.

Leuk Res. 2013 Jul;37(7):742-6. doi: 10.1016/j.leukres.2013.04.015. Epub 2013 May 1.

PMID:
23643325
14.

Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes.

Voso MT, Fabiani E, D'Alo' F, Guidi F, Di Ruscio A, Sica S, Pagano L, Greco M, Hohaus S, Leone G.

Ann Oncol. 2007 Sep;18(9):1523-8.

PMID:
17761709
15.

Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia.

Seedhouse C, Faulkner R, Ashraf N, Das-Gupta E, Russell N.

Clin Cancer Res. 2004 Apr 15;10(8):2675-80.

16.

Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia.

Sasai Y, Horiike S, Misawa S, Kaneko H, Kobayashi M, Fujii H, Kashima K, Taniwaki M.

Leuk Res. 1999 Nov;23(11):975-81.

PMID:
10576500
17.

Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms.

Nardi V, Winkfield KM, Ok CY, Niemierko A, Kluk MJ, Attar EC, Garcia-Manero G, Wang SA, Hasserjian RP.

J Clin Oncol. 2012 Jul 1;30(19):2340-7. doi: 10.1200/JCO.2011.38.7340. Epub 2012 May 14.

18.

Glutathione S-transferase polymorphisms in children with myeloid leukemia: a Children's Cancer Group study.

Davies SM, Robison LL, Buckley JD, Radloff GA, Ross JA, Perentesis JP.

Cancer Epidemiol Biomarkers Prev. 2000 Jun;9(6):563-6.

19.

Association of glutathione S-transferase, EPHX, and p53 codon 72 gene polymorphisms with adult acute myeloid leukemia.

Chauhan PS, Ihsan R, Yadav DS, Mishra AK, Bhushan B, Soni A, Kaushal M, Devi TR, Saluja S, Gupta DK, Mittal V, Saxena S, Kapur S.

DNA Cell Biol. 2011 Jan;30(1):39-46. doi: 10.1089/dna.2010.1092. Epub 2010 Aug 23.

PMID:
20731606
20.

Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.

Ok CY, Patel KP, Garcia-Manero G, Routbort MJ, Fu B, Tang G, Goswami M, Singh R, Kanagal-Shamanna R, Pierce SA, Young KH, Kantarjian HM, Medeiros LJ, Luthra R, Wang SA.

Leuk Res. 2015 Mar;39(3):348-54. doi: 10.1016/j.leukres.2014.12.006. Epub 2014 Dec 20.

Supplemental Content

Support Center